Navigation Links
Ennova Direct Announces the Sale of its Consumer Electronics/Computer Peripheral Patent Portfolio
Date:4/5/2011

SCOTTS VALLEY, Calif., April 5, 2011 /PRNewswire/ -- Ennova Direct, Inc. (DBA ION Technologies) announced today that they're offering a patent portfolio for sale that is focused on Retractable USB Flash Drive Devices, Retractable Biometric USB Flash Drive Devices, MP3 Players (wired and Wireless Bluetooth™) and Wireless Bluetooth Earbud Headsets. In total the intellectual property includes 6 issued US patents (US 6,979,210, US 7,040,425, US 7,090,515, US 7,462,044, US 7,566,231 and US 7,747,003 plus two published applications (US 2006/240,692 & US 2008/050,952).

"Our revised business model is devoted to inventing and patenting new technology which we sell to Operating Companies looking for new technology to build to or to Non Practicing Entities (NPE) looking for valuable intellectual property to add to their portfolios. There are patents within this portfolio that have been heavily adopted across multiple industries and the buyer of the portfolio will be able to protect and enforce in multiple areas. This presents a great opportunity for a large return on investment," said Peter Garrett, President of Ennova Direct, Inc.

Patents within the portfolio are proven intellectual property. They have already been licensed to A-DATA Technology, Philips Electronics, PNY Technologies, Sony Corporation of America, Transcend Information, Verbatim Americas and more.

In addition to any existing market adoption, there is other intellectual property within the portfolio that is poised for heavy market growth: Patent No.: US, 7462, 044, the world's first retractable USB flash drive with a biometric fingerprint scanner embedded into an OLED touchscreen, or US 7,747,003, the world's first wireless Bluetooth stereo earbud headset, the first stereo Bluetooth invention to completely cu
'/>"/>

SOURCE Ennova Direct, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors
2. Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready
3. Virtual reality: Keyhole surgeons training could help meet European working time directives
4. Director of Berman Institute comments on FDA Approval of first human embryonic stem cell trial
5. Rewrite the textbooks: Transcription is bidirectional
6. Genetic study shows direct link between vitamin D and MS susceptibility gene
7. Fujitsu PalmSecure LOGONDIRECTOR Integrates with Passlogix v-GO Access Accelerator Suite
8. Human ES cells progress slowly in myelins direction
9. Signals from stroking have direct route to brain
10. Fujitsu PalmSecure LOGONDIRECTOR Integrates with Passlogix v-GO Access Accelerator Suite
11. MBL director and CEO and cell biology pioneer Gary Borisy elected to National Academy of Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... treatment for a brain infection caused by fungus could now ... to study by University of Liverpool scientists. , Cryptococcus ... fatal but are relatively neglected in medical research. They ... Australasia and South East Asia and mainly affect people with ... a year. , The University research team has tested the ...
(Date:4/24/2014)... the largest river turtle in North America, weighing in ... century. Now researchers from Florida and the University of ... but three. , Examining museum specimens and wild ... ancient reptile. , Once heavily hunted for turtle meat ... Turtle Soup in the 1960s the riverine populations ...
(Date:4/23/2014)... chronic inflammatory disorders among people of lower socioeconomic status ... to the microbes that thrive in rural environments, according ... in the journal Clinical & Experimental Immunology , ... less access to green spaces may be more apt ... system dysfunction. , When our immune systems are working ...
Breaking Biology News(10 mins):Treatment for deadly yeast disease reduced to 3 days 2Two new US turtle species described 2Two new US turtle species described 3Rural microbes could boost city dwellers' health 2Rural microbes could boost city dwellers' health 3
... Mellon University,s Philip R. LeDuc and his collaborators in ... a protein that could ultimately unlock the mystery of ... role in the mechanics of biological processes in people. ... function of a protein that helps control cell behavior ...
... Reunion in the Indian Ocean and collaborating with researchers at ... sensitive night cameras to capture the first known occurrence of ... only is this the first time this behaviour has been ... who are better known for eating plants but ...
... number of scientists are merging methods and results from different ... team of researchers in a recent issue of Evolution ... new data, however, researchers who want to analyze previous findings ... the authors say. In a commentary piece in the journal ...
Cached Biology News:Carnegie Mellon's Philip LeDuc discovers new protein function 2First known instance of a cricket as an orchid pollinator captured on film by Kew scientist 2Biologists merge methods, results from different disciplines to find new meaning in old data 2Biologists merge methods, results from different disciplines to find new meaning in old data 3
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging ... to serve the wound care market. , Free report ... was restructured with a seasoned management team and Board, ...
(Date:1/14/2014)... 2014 iLab Solutions, the leader in core ... Director of Product Strategy. In this role, Michelle will work ... to guide in the development of iLab products. Her main ... possible benefit to the scientific community by offering the most ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... , EMERYVILLE, Calif., Aug. 6 Onyx Pharmaceuticals, ... to sell an aggregate of four million shares of its common stock ... million aggregate principal amount of its 4.00% convertible senior notes due 2016 ... options to purchase up to an additional 600,000 shares of its common ...
... , ALBANY, Ore., Aug. 6 Synthetech, Inc. (OTC ... of fiscal 2010, which ended June 30, 2009. Revenue for ... of $4.9 million in the first quarter of fiscal 2009. ... operating income of $314,000 for the same period last year. ...
... Md., Aug. 6 Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: ... of clinical-stage product candidates for central nervous system disorders, today announced ... on Monday, August 10, 2009, before the market opens. A full ... , , Mihael H. Polymeropoulos, M.D., President and ...
Cached Biology Technology:Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes 2Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes 3Synthetech Reports First Quarter Fiscal 2010 Results 2Synthetech Reports First Quarter Fiscal 2010 Results 3Synthetech Reports First Quarter Fiscal 2010 Results 4Synthetech Reports First Quarter Fiscal 2010 Results 5Synthetech Reports First Quarter Fiscal 2010 Results 6Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009 2
Application: for RNase- decontamination , Registered Trademark of Ambion. ,Special grade: for molecular biology Density: 1.00 g/mL (20 C) Suitab tst: RNase decontamination in accordance...
With L-glutamine and potassium bicarbonate. Sterile, Insect cell culture tested...
... meet the needs of the ... medium supports fast cell growth ... while maintaining high cell viability ... using the Baculovirus Expression Vector ...
Mol wt: average mol wt12,360.96 Da by calculation...
Biology Products: